Bayer - Homepage

News

July 9, 2009

Expansion of diabetes portfolio in growth market China:
Bayer acquires exclusive rights to Bioton’s insulin SciLin® » more

1:14 min.

July 8, 2009

Bayer submits first-in-class estradiol-based oral contraceptive for approval in the U.S. » more

1:05 min.

July 7, 2009

Bayer MaterialScience declares force majeure for TDI in Europe » more

News Overview

Bayer Group
report - The Bayer Company Magazine
China: Hope returns after the earthquake. Bayer supports the victims of the earthquake disaster in 2008. » Download and subscription

Research & Innovation
Scientist elucidates
chemistry of life
Professor Patrick Cramer and his team have elucidated the chemical processes which turn the building blocks of DNA into a living, biological process.

4:57 min.

Research & Innovation
New technologies help cancer patients
At the Annual Meeting of U.S. oncologists, Bayer presented the most recent data on its anticancer active ingredient sorafenib – a success story.

7:20 min.

Sustainability & Commitment
Sustainable Development Report 2008
The goal of our report is to give our stakeholders comprehensive and candid information on how we as a company are promoting global sustainable development. » more